This R04-8F7 recombinant monoclonal antibody has the ability to specifically bind to human PRKRA. It cross-reacts with mouse, rat. The specificity of the PRKRA antibody was confirmed by western blot analysis of PABPN1 in Jurkat, Hela, COS7, Raji lysates and immunohistochemistry analysis of paraffin-embedded human breast cancer.
Figure 1 Anti-PRKRA Antibody (VS3-FY1813) in WB.
The PABPN1 expression in Jurkat, Hela, COS7, Raji lysates were detected using the anti-PABPN1 by western blot assay.
Figure 2 Anti-PRKRA Antibody (VS3-FY1813) in IHC.
Immunohistochemistry staining of paraffin-embedded human breast cancer using the anti-PABPN1 antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1528CT | Recombinant Mouse anti-Human PRKRA Monoclonal antibody (EML878) | IHC-P, WB |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-2864 | Hi-Affi™ Recombinant Rabbit Anti-PRKRA Monoclonal Antibody (DS2864AB) | WB, IHC-P | IgG |
There are currently no Customer reviews or questions for VS3-FY1813. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.